Literature DB >> 19509354

How well do angiogenesis inhibitors work? Biomarkers of response prove elusive.

Vicki Brower.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19509354     DOI: 10.1093/jnci/djp171

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.

Authors:  Seiji Mabuchi; Chiaki Kawase; Deborah A Altomare; Kenichirou Morishige; Masami Hayashi; Kenjiro Sawada; Kimihiko Ito; Yoshito Terai; Yukihiro Nishio; Andres J Klein-Szanto; Robert A Burger; Masahide Ohmichi; Joseph R Testa; Tadashi Kimura
Journal:  Mol Cancer Ther       Date:  2010-07-27       Impact factor: 6.261

2.  Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.

Authors:  Wen-Jane Lee; Keng-Hsin Lan; Chiang-Ting Chou; Yu-Chiao Yi; Wei-Chih Chen; Hung-Chuan Pan; Yen-Chun Peng; Keh-Bin Wang; Yi-Ching Chen; Te-Hsin Chao; Hsing-Ru Tien; Wayne Huey Herng Sheu; Meei-Ling Sheu
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

3.  Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.

Authors:  Carmine Carbone; Tania Moccia; Cihui Zhu; Genni Paradiso; Alfredo Budillon; Paul J Chiao; James L Abbruzzese; Davide Melisi
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

4.  EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.

Authors:  Mototaka Sato; Yasutomo Nakai; Wataru Nakata; Takahiro Yoshida; Koji Hatano; Atsunari Kawashima; Kazutoshi Fujita; Motohide Uemura; Hitoshi Takayama; Norio Nonomura
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 5.  Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.

Authors:  Hye Won Lee; Han Yong Choi; Kyeung Min Joo; Do-Hyun Nam
Journal:  Int J Mol Sci       Date:  2015-02-25       Impact factor: 5.923

6.  Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.

Authors:  Yun Mi Lee; Yu-Ri Lee; Chan-Sik Kim; Kyuhyung Jo; Eunjin Sohn; Jin Sook Kim; Junghyun Kim
Journal:  Int J Mol Sci       Date:  2015-12-16       Impact factor: 5.923

7.  A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.

Authors:  Arianna Giacomini; Sara Matarazzo; Katiuscia Pagano; Laura Ragona; Sara Rezzola; Michela Corsini; Emanuela Di Salle; Marco Presta; Roberto Ronca
Journal:  Oncotarget       Date:  2015-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.